The news is a setback for Pfizer as it aims to build a large arsenal of anti-cancer medicines to help it grow earnings before big sellers like Lipitor, the top-selling medicine in the world, lose patent protection in coming years.

FORBES: Magazine Article

The news is a setback for Pfizer (nyse: PFE - news - people ) as it aims to build a large arsenal of anti-cancer medicines to help it grow earnings before big sellers like Lipitor, the top-selling medicine in the world, lose patent protection in coming years.

FORBES: Pfizer Stops Developing Coley Cancer Drug

In one tantalizing moment, Andrew Dannenberg , a cancer prevention guru from Cornell University, said that a trial he was working on using older anti-inflammatory drugs had found these medicines--drugs like ibuprofen and naproxen--had prevented cancer but caused heart attacks.

FORBES: Pfizer And Merck Face The Jury